Literature DB >> 7045239

Laminin and bullous pemphigoid antigen are distinct basement membrane proteins synthesized by epidermal cells.

J R Stanley, P Hawley-Nelson, M Yaar, G R Martin, S I Katz.   

Abstract

We sought to determine if laminin, a high molecular weight glycoprotein of basement membrane, is synthesized by epidermal cells and whether it is distinct from bullous pemphigoid (BP) antigen, another high molecular weight-protein of basement membrane. By indirect immunofluorescence we detected laminin in cultures of Pam cells ( a mouse keratinocyte cell line) and normal human epidermal cells. To directly demonstrate its biosynthesis, we labeled the cells with radioactive amino acids and then extracted the cell layers with nonionic detergent. Using immunoprecipitation followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography to identify radiolabeled laminin, we could precipitate the 2 chains of laminin from cell culture medium and extracts of the cell layers. BP antigen, immunoprecipitated from the cells, did not comigrate with laminin on SDS-PAGE. In addition, BP antigen could be immunoprecipitated from the cell extracts depleted of laminin, and conversely, laminin could be immunoprecipitated from cell extracts depleted of BP antigen. We conclude that laminin is synthesized by epidermal cells (specifically, keratinocytes) and is distinct from BP antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7045239     DOI: 10.1111/1523-1747.ep12510132

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Evidence that mineralized spherules are involved in the formation of the superficial layer of the elasmoid scale in cichlids Cichlasoma octofasciatum and Hemichromis bimaculatus (Pisces, Teleostei): an epidermal active participation?

Authors:  J Y Sire
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

3.  Epithelial-mesenchymal interactions control basement membrane production and differentiation in cultured and transplanted mouse keratinocytes.

Authors:  A Bohnert; J Hornung; I C Mackenzie; N E Fusenig
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

4.  Expression of laminin, type IV procollagen and 230 kDa bullous pemphigoid antigen genes by keratinocytes and fibroblasts in culture: application of the polymerase chain reaction for detection of small amounts of messenger RNA.

Authors:  K Nomura; T Sugawara; T Sato; D Sawamura; I Hashimoto; Y Sugita; J Uitto
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Glycoproteins and glycosaminoglycans synthesized by human keratinocytes in culture. Their role in cell-substratum adhesion.

Authors:  G P Roberts; L Jenner
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

6.  Decreased anchoring-fibril antigens (AF1 and AF2) in basal-cell carcinoma.

Authors:  A T Lane; L A Goldsmith; P E McCoon; J E Muhlbauer
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

7.  Induction of nerve growth factor receptors on cultured human melanocytes.

Authors:  M Peacocke; M Yaar; C P Mansur; M V Chao; B A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 8.  Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases.

Authors:  P Bernard
Journal:  Springer Semin Immunopathol       Date:  1992

9.  The dermal-epidermal junction of human skin contains a novel laminin variant.

Authors:  M P Marinkovich; G P Lunstrum; D R Keene; R E Burgeson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Regional variations in antigenic properties of skin. A possible cause for disease-specific distribution of skin lesions.

Authors:  L Sison-Fonacier; J C Bystryn
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.